Bacille calmette-guérin lymphadenitis and immune reconstitution syndrome in HIV-infected children on antiretroviral therapy in Jamaica

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 302-306

  Dunkley Thompson, J ^a,c   Pierre, R B ^a,b   Steel Duncan, J ^a,b   Palmer, P ^a,b   Davis, D ^a   Figueroa, J P ^d   Christie, Celia D C ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^c Mandeville Regional Hospital   (Jamaica)

^d Ministry of Health   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; ZIDOVUDINE;

ACID FAST BACTERIUM; ANEMIA; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; COAGULASE NEGATIVE STAPHYLOCOCCUS; DERMATITIS; DEVELOPMENTAL DISORDER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAILURE TO THRIVE; FEMALE; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; INJECTION SITE ABSCESS; INJECTION SITE ULCER; JAMAICA; LYMPH NODE BIOPSY; LYMPHADENITIS; MALE; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; SKIN TOXICITY; SURGICAL DRAINAGE; THRUSH; TUBERCULOSIS; WASTING SYNDROME;

ADJUVANTS, IMMUNOLOGIC; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BCG VACCINE; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; JAMAICA; LYMPHADENITIS; MALE;

EID: 55749086955     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Grange JM, Gibson J, Osborn TW, Collins CH, Yates MD. What is BCG? Tubercle 1983; 64: 129-39.
2. The MASS BCG vaccination campaign in Jamaica. Bol Oficina Sanit Panam 1957; 43: 61-76.
3. Romanus V. Tuberculosis in Bacillus Calmette-Guérin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guérin immunization of the newborn in 1975. Pediatr Infect Dis 1987; 6: 272-80.
4. Padungchan S, Konjanart S, Kasiratta S, Daramas S, ten Dam HG. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok. Bull World Health Organ 1986; 64: 247-58.
5. Tidjani O, Amedome A, ten Dam HG. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle 1986; 67: 269-81.
6. Young TK, Hershfield ES. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health 1986; 76: 783-6.
7. Shapiro C, Cook N, Evans D, Willett W, Fajardo I, Koch-Weser D et al. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. Int J Epidemiol 1985; 14: 441-6.
8. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22: 1154-8.
9. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994; 271: 698-702.
10. Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996; 45: 1-18. Accessed September 13, 2007 at http://www.cdc.gov/mmwr/PDF/rr/rr4504.PDF.
11. Praveen KN, Smikle MF, Prabhakar P, Pande D, Johnson B, Ashley D. Outbreak of Bacillus Calmette-Guerin associated lymphadenitis and abscesses in Jamaican children. Pediatric Infect Dis J 1990; 9: 890-93.
12. Helmick CG, D'Souza AJ, Goddard RN. An outbreak of severe BCG axillary lymphadenitis in Saint Lucia, 1982-1983. West Indian Med J 1986; 35: 12-17.
13. Sharp MJ, Mallon DF. Regional bacillus Calmette-Guerin lymphadenitis after initiating antiretroviral therapy in an infant with human immunodeficiency virus-1 infection. Pediatr Infect Dis J 1998; 17: 660-2.
14. Hesseling AC, Schaaf HS, Hanekom WA, Beyers N, Cotton MF, Gie RP et al. Danish bacilli Calmette-Guerin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 2003; 37: 1226-33.
15. Puthanakit T, Oberdorfer P, Punjaisee S, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome due to bacillus Calmette-Guerin after initiation of antiretroviral therapy in children with HIV infection. Clin Infect Dis. 2005; 41: 1049-52.
16. Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatric Infect Dis J 2006; 25: 53-8.
17. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 2002; 81: 213-27.
18. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38:1159-66.
19. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615-27.
20. Pires A, Nelson M, Pozniak AL, Fisher M, Gazzard B, Gotch F et al. Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy. J Immune Based Ther Vaccines 2005; 3: 7.
21. Lawn S, Bekker L, Miller R. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005; 5: 361-73.
22. Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, Schaaf HS et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006; 42: 548-58.
23. Siberry GK, Tessema S. Immune reconstitution syndrome precipitated by bacilli Calmette Guerin after initiation of antiretroviral therapy. Pediatr Infect Dis J 2006; 25: 648-9.
24. Noah PK, Pande D, Johnson B, Ashley D. Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guerin lymphadenitis and abscesses. Pediatric Infect Dis J 1993; 12: 136-9.
25. Goraya JS, VirdiVS. Bacille Calmette-Guerin lymphadenitis. Postgrad Med J 2002; 78: 327-9.
26. Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994; 71: 446-7.
27. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003; 81: 61-70.
28. World Health Organization. Safety of BCG vaccine in HIV-infected children. Wkly Epidemiol Rec. 2007; 82: 17-24. Accessed September 15, 2007 at http://www.who.int/wer.
29. Williams B, Grigsby ME. Mycobacteriosis: incidence in Jamaican basic school children. J Natl Med Assoc 1976; 68: 39-41, 33.
30. Geoghagen M, Farr JA, Hambleton I, Pierre R, Christie CDC. Tuberculosis and HIV co-infections in Jamaican children. West Indian Med J 2004; 53: 271-365.
31. National HIV/STI Programme, Ministry of Health (MOH). PMTCT+ Integrating treatment, care and support with prevention of mother to child transmission of HIV services; implementation guidelines for healthcare workers. Jamaica: National HIV/STI Programme, MOH; 2006.